Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis

Pituitary

Volumn 12, Issue 4, 2009, Pages 315-321

  Nascif, Sergio Oliva ^a   Molica, Patrícia ^a   Correa Silva, Silvia Regina ^a   Silva, Marcos Roberto ^a   Lengyel, Ana Maria Judith ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ACTH; Cortisol; Ghrelin; Thyrotoxicosis

Indexed keywords

GHRELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HYDROCORTISONE; THYROID HORMONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DRUG EFFICACY; FACIAL FLUSHING; FEMALE; FLUSHING; HORMONE RESPONSE; HUMAN; HUNGER; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; THYROID HORMONE BLOOD LEVEL; THYROTOXICOSIS;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; GHRELIN; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; OLIGOPEPTIDES; PITUITARY-ADRENAL SYSTEM; THYROTOXICOSIS; YOUNG ADULT;

EID: 70350295883     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-009-0181-3     Document Type: Article

References (41)

1. Melmed S, Kleinberg D (2008) Anterior Pituitary. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 155-261
2. Levin ME, Daughaday WH (1955) The influence of the thyroid on adrenocortical function. J Clin Endocrinol Metab 15:1494-1510
3. Peterson RE (1958) The influence of the thyroid on adrenal cortical function. J Clin Invest 37:736-743. doi: 10.1172/JCI103659
4. Gordon GG, Southren AL (1977) Thyroid-hormone effects on steroid-hormone metabolism. Bull N Y Acad Med 53:241-254
5. Jackson IMD, Hassan THA, Prentice CRM, Browning MCK (1966) Insulin-induced hypoglycemia as a test of pituitary-adrenal function in thyrotoxicosis. J Clin Endocrinol 26:545-549
6. Tsatsoulis A, Johnson EO, Kalogera CH, Seferiadis K, Tsolas O (2000) The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol 142:231-235. doi: 10.1530/eje.0.1420231
7. Goswami R, Kochupillai N (2001) Adrenocortical reserves in patients with Graves' disease. Eur J Endocrinol 144:85. doi: 10.1530/eje.0.1440085
8. Yamakita N, Murai T, Kokubo Y, Hayashi M, Akai A, Yasuda K (2001) Dehydroepiandrosterone sulphate is increased and dehydroepiandrosterone-response to corticotrophin-releasing hormone is decreased in the hyperthyroid state compared with the euthyroid state. Clin Endocrinol (Oxf) 55:797-803. doi: 10.1046/j.1365-2265.2001.01420.x
9. Giustina G, Reschini E, Valentini F, Cantalamessa L (1971) Growth hormone and cortisol responses to insulin-induced hypoglycemia in thyrotoxicosis. J Clin Endocrinol 32:571-574
10. Brauman H, Smets P, Corvilain J (1973) Comparative study of growth response to hypoglycemia in normal subjects and in patients with primary myxedema or hyperthyroidism before and after treatment. J Clin Endocrinol Metab 36:1162-1174
11. Moghetti P, Castello R, Tosi F et al (1994) Glucose counterregulatory response to acute hypoglycemia in hyperthyroid human subjects. J Clin Endocrinol Metab 78:169-173. doi: 10.1210/jc.78.1.169
12. Dumoulin SC, Perret BP, Bennet AP, Caron PJ (1995) Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans. Eur J Endocrinol 132:594-598. doi: 10.1530/eje.0.1320594
13. Mishra SK, Gupta N, Goswami R (2007) Plasma adrenocorticotropin (ACTH) values and cortisol response to 250 and 1 μg ACTH stimulation in patients with hyperthyroidism before and after carbimazole therapy: case-control comparative study. J Clin Endocrinol Metab 92:1693-1696. doi: 10.1210/jc.2006-2090
14. Kamilaris TC, DeBold CR, Johnson EO et al (1991) Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128:2567-2576
15. Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP (2005) Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 153:177-185. doi: 10.1530/eje.1.01923
16. Lizcano F, Salvador J (2008) Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. Clin Exp Pharmacol Physiol 35:1085-1090. doi: 10.1111/j.1440-1681.2008.04966.x
17. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660. doi: 10.1038/45230
18. Gnanapavan S, Kola B, Bustin SA et al (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991. doi: 10.1210/jc.87.6.2988
19. van der Lely AJ, Tschop M, Heiman ML, Ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457. doi: 10.1210/er.2002-0029
20. Korbonits M, Kaltsas G, Perry LA et al (1999) The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84:2489-2495. doi: 10.1210/jc.84.7.2489
21. Arvat E, Maccario M, di Vito L et al (2001) Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174. doi: 10.1210/jc.86.3.1169
22. Coiro V, Saccani-Jotti G, Minelli R et al (2005) Adrenocorticotropin/ cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men. Neuroendocrinology 81:103-106. doi: 10.1159/ 000085541
23. Correa-Silva SR, Nascif SO, Lengyel AM (2006) Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: Comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. Pituitary 9:101-107. doi: 10.1007/s11102-006-9149-8
24. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947. doi: 10.1210/jc.80.3.942
25. Popovic V, Miljic D, Micic D et al (2003) Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab 88:3450-3453. doi: 10.1210/jc.2003-030211
26. Hickey GJ, Drisko J, Faidley T et al (1996) Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692, 585. J Endocrinol 148:371-380. doi: 10.1677/ joe.0.1480371
27. Schleim K-D, Jacks T, Cunningham P et al (1999) Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation. Endocrinology 140:1552-1558. doi: 10.1210/en.140.4.1552
28. Bennett PA, Thomas GB, Howard AD et al (1997) Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138:4552-4557. doi: 10.1210/ en.138.11.4552
29. Guan X, Yu H, Palyha OC et al (1997) Distribution of mRNA encoding the growth hormone secretagogues receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48:23-29. doi: 10.1016/S0169-328X(97)00071-5
30. Mozid AM, Tringali G, Forsling ML et al (2003) Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 35:455-459. doi: 10.1055/s-2003-41801
31. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004) Ghrelin - a hormone with multiple functions. Front Neuroendocrinol 25:27-68. doi: 10.1016/j.yfrne.2004.03.002
32. Molica P, Nascif SO, Correa-Silva SR, Silva MR, Sa LBC, Lengyel AMJ (2007) Increased GHRP-6 and ghrelin-induced ACTH release in thyrotoxicosis. Program of the 89th annual meeting of the endocrine society, Toronto, Canada, 2007, pp 348-349 (AbstractP2-89)
33. Davies TF, Larsen PR (2008) Thyrotoxicosis. In: Kronenberg HM (ed) Williams textbook of endocrinology, 11th edn. Saunders Elsevier, Philadelphia, pp 333-375
34. Giordano R, Balbo M, Picu A et al (2006) Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: Evidence for subclinical primary hypoadrenalism? Eur J Endocrinol 155:421-428. doi: 10.1530/ eje.1.02222
35. Elias KA, Ingle GS, Burnier JP et al (1995) In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699. doi: 10.1210/en.136.12.5694
36. Smith RG, Van der Ploeg LH, Howard AD et al (1997) Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645. doi: 10.1210/er.18.5.621
37. Thomas GB, Fairhall KM, Robinson ICAF (1997) Activation of the hypothalamic-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585-1591. doi: 10.1210/en.138.4.1585
38. Korbonits M, Little JA, Forsling ML et al (1999) The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 11:521-528. doi: 10.1046/j.1365-2826.1999.00353.x
39. Wren AM, Small CJ, Fribbens CV et al (2002) The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76:316-324. doi: 10.1159/000066629
40. Kaji H, Kishimoto M, Kirimura T et al (2001) Hormonal regulation of the human ghrelin receptor gene transcription. Biochem Biophys Res Commun 284:660-666. doi: 10.1006/bbrc.2001.5035
41. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM (2001) Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 142:2649-2659. doi: 10.1210/ en.142.6.2649